Role of Uterine NK Cell Activation Markers NKp46 and NKG2D in Endometriosis Related Infertility
Journal of Reproduction & Infertility · 01.11.2026
DOI: 10.18502/jri.v27i2.23147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproduction & Infertility, online erschienen am 01.11.2026. Verfasst von Alfin Firasy Mufid und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Endometriosis, affecting 10–40% of infertile women, is associated with endometrial immune dysregulation. Uterine natural killer (uNK) cells play pivotal roles in implantation and endometrial immune regulation. However, the differential expression of the activating receptors NKp46 and NKG2D between CD56bright and CD56dim uNK cell subsets in endometriosis-associated infertility remains poorly characterized. This study investigated these receptor profiles in infertile women with endometriosis.
Methods
Endometrial biopsies from 14 women with endometriosis and 21 controls were analyzed by flow cytometry. Disease severity was assessed using the revised American Society for Reproductive Medicine (rASRM) classification. Group comparisons and correlations were evaluated using appropriate statistical tests, with p
Zitieren
APA
Mufid, A. F., Ahsan, F., Santoso, B., Rahmawati, N. Y., & Alditia, F. N. (2026). Role of Uterine NK Cell Activation Markers NKp46 and NKG2D in Endometriosis Related Infertility. Journal of Reproduction & Infertility. https://doi.org/10.18502/jri.v27i2.23147
Vancouver
Mufid AF, Ahsan F, Santoso B, Rahmawati NY, Alditia FN. Role of Uterine NK Cell Activation Markers NKp46 and NKG2D in Endometriosis Related Infertility. Journal of Reproduction & Infertility. 2026. doi:10.18502/jri.v27i2.23147
BibTeX
@article{Mufid2026,
author = {Mufid, Alfin Firasy and Ahsan, Fadhil and Santoso, Budi and Rahmawati, Nanda Yuli and Alditia, Fidyah Nanda},
title = {Role of Uterine NK Cell Activation Markers NKp46 and NKG2D in Endometriosis Related Infertility},
journal = {Journal of Reproduction & Infertility},
year = {2026},
doi = {10.18502/jri.v27i2.23147}
}
EUVIMED